Form 4: Century Therapeutics SVP Sells Shares to Cover Tax Obligations

Douglas Carr, SVP of Finance & Operations at Century Therapeutics, sold 289 shares of common stock on August 5, 2024, to cover tax withholding obligations related to vesting restricted stock units.

Summary

• On August 5, 2024, Douglas Carr, the SVP of Finance & Operations at Century Therapeutics, sold 289 shares of the company's common stock.
• The sale was executed at a price of $1.827 per share.
• This transaction was conducted to cover tax withholding obligations associated with the vesting of restricted stock units.
• Following the transaction, Carr still beneficially owns 334,041 shares of Century Therapeutics stock.

Sentiment

Score: 5

Explanation: The document is a routine regulatory filing related to an insider stock sale for tax purposes. It doesn't convey any particularly positive or negative sentiment about the company's prospects.

Management Comments

• The sales reported on this Form 4 represent the number of shares required to be sold by the Reporting Person to cover tax withholding obligations in connection with the vesting of restricted stock units.
• Such sales were automatic and not at the discretion of the Reporting Person.

Industry Context

Form 4 filings are standard procedure when company insiders, like officers and directors, trade their company's stock. These filings are publicly available and provide transparency into insider transactions.

Stakeholder Impact

• The sale of shares by an insider could be perceived negatively by some shareholders, but the explanation provided suggests it was a routine transaction for tax purposes.

Key Dates